Commencement of the trial batches at Talod Plant.

Date: 07-10-2026 The Manager, Department of Corporate Services, BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai - 400 001. Scrip Code : 544460 Dear Sir/Madam, Sub: Submission of Press Release pertaining to Talod Plant. Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit the Press Release pertaining to the commencement of the Trail Batches. We request you to kindly take the same on record and treat this submission as compliance with the applicable provisions of the SEBI Listing Regulations. Yours faithfully, Patel Chem Specialities Limited Bhupesh Patel Managing Director DIN: 02075545 Patel Chem Specialities Ltd Completes Talod Facility (2nd) Expansion, Scaling Capacity ~6.25× to 4,500 MT Ahmedabad, October 7, 2026 - Patel Chem Specialities Limited, a manufacturer of pharmaceutical excipients and speciality chemicals, has successfully completed the expansion of its manufacturing facility at Talod, Gujarat, significantly enhancing the plant’s annual production capacity from 720 MTPA to 4,500 MTPA. The expansion marks an important milestone in the Company’s growth strategy and is aimed at addressing anticipated growth in product demand while enabling shorter delivery schedules for customers. Trial batches at the expanded facility have already commenced, and the Company expects to begin commercial production from the enhanced capacity shortly. The increased manufacturing capacity is expected to strengthen Patel Chem Specialities Limited’s ability to cater to growing market requirements and support its future business growth. Glimpses of Talod’s Manufacturing Facility 1 | Page Key Highlights 1. Expanded Production Capacity: 4,500 MT per annum 2. Facility: TALOD PLANT, GUJARAT 3. Status: Expansion successfully completed 4. Trial Batches: Commenced 5. Commercial Production: Expected to commence shortly 6. Capital Expenditure: Approximately ₹20 crore 7. Funding: Bank loans and internal accruals 8. Expansion Objective: To cater to anticipated growth in demand and facilitate shorter delivery schedules Management Commentary Commenting on the development, Mr. Bhupesh Patel, Managing Director of Patel Chem Specialities Limited said: “The successful completion of the expansion at our Talod facility represents an important step in strengthening our manufacturing capabilities. With the enhanced capacity from 720 MT per annum to 4,500 MT per annum, we are better positioned to cater to growing market demand and improve delivery timelines for our customers. At peak utilisation levels, the Talod facility has the potential to generate annual revenue of approximately ₹85–100 crore. As trial batches have already commenced, we look forward to commencing commercial production from the expanded facility shortly and leveraging the additional capacity to support the Company’s future growth.” About Patel Chem Specialities Limited Patel Chem Specialities Limited operates in the specialty chemicals industry, with a focus on cellulose- based excipients and speciality chemicals used across pharmaceutical, food & beverage, cosmetics and industrial applications. The Company has 3 manufacturing facilities located at Vatva, Ahmedabad; Talod, Himmatnagar; and Indrad, Mehsana, supporting its production capabilities and expanding product requirements across key end-user industries. With a diversified B2B customer base, the Company caters to both domestic and international markets, with its products finding applications across regulated and quality-sensitive industries. The Company’s operations are supported by a strong focus on quality, regulatory compliance and consistent product standards, with certifications including US-DMF, GMP and ISO 9001:2015. 2 | Page Disclaimer Certain statements in this document that are not historical facts are forward looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local, political or economic developments, technological risks, and many other factors that could cause actual results to differ materially from those contemplated by the relevant forward-looking statements. The Company will not be in any way responsible for any action taken based on such statements and undertakes no obligation to publicly update these forward-looking statements to reflect subsequent events or circumstances. Investor Relations Partner ORIM CONNECT +(91) 83693 82388 letsconnect@orim.in www.orim.in/orim-connect/ 3 | Page